Research ExplorerPublicationsThe influence of tamoxifen on the secretion of transforming ...

The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings.

Standard

The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings. / Puchner, Maximilian J A; Köppen, Johannes; Zapf, Svenja; Knabbe, Cornelius; Westphal, Manfred.

In: ANTICANCER RES, Vol. 22, No. 1, 1, 2002, p. 45-51.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Puchner, MJA, Köppen, J, Zapf, S, Knabbe, C & Westphal, M 2002, 'The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings.', ANTICANCER RES, vol. 22, no. 1, 1, pp. 45-51. <http://www.ncbi.nlm.nih.gov/pubmed/12017331?dopt=Citation>

APA

Puchner, M. J. A., Köppen, J., Zapf, S., Knabbe, C., & Westphal, M. (2002). The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings. ANTICANCER RES, 22(1), 45-51. [1]. http://www.ncbi.nlm.nih.gov/pubmed/12017331?dopt=Citation

Vancouver

Puchner MJA, Köppen J, Zapf S, Knabbe C, Westphal M. The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings. ANTICANCER RES. 2002;22(1):45-51. 1.

Bibtex

@article{a6453c8daaa046db83dfeec4cc77e5a8,
title = "The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings.",
abstract = "Only a minority of patients with malignant gliomas respond to continuous high-dose tamoxifen (TAM) treatment. Therefore a method to predict the efficiency of TAM-treatment would be desirable. Analogous to previous studies in breast cancer patients, we investigated whether the dynamics of TGF-beta2 plasma levels allow the prediction of response to TAM-treatment in glioblastoma patients as well.",
author = "Puchner, {Maximilian J A} and Johannes K{\"o}ppen and Svenja Zapf and Cornelius Knabbe and Manfred Westphal",
year = "2002",
language = "Deutsch",
volume = "22",
pages = "45--51",
journal = "ANTICANCER RES",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1",

}

RIS

TY - JOUR

T1 - The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings.

AU - Puchner, Maximilian J A

AU - Köppen, Johannes

AU - Zapf, Svenja

AU - Knabbe, Cornelius

AU - Westphal, Manfred

PY - 2002

Y1 - 2002

N2 - Only a minority of patients with malignant gliomas respond to continuous high-dose tamoxifen (TAM) treatment. Therefore a method to predict the efficiency of TAM-treatment would be desirable. Analogous to previous studies in breast cancer patients, we investigated whether the dynamics of TGF-beta2 plasma levels allow the prediction of response to TAM-treatment in glioblastoma patients as well.

AB - Only a minority of patients with malignant gliomas respond to continuous high-dose tamoxifen (TAM) treatment. Therefore a method to predict the efficiency of TAM-treatment would be desirable. Analogous to previous studies in breast cancer patients, we investigated whether the dynamics of TGF-beta2 plasma levels allow the prediction of response to TAM-treatment in glioblastoma patients as well.

M3 - SCORING: Zeitschriftenaufsatz

VL - 22

SP - 45

EP - 51

JO - ANTICANCER RES

JF - ANTICANCER RES

SN - 0250-7005

IS - 1

M1 - 1

ER -